Sartorius AG (XTER:SRT3) ROE % Adjusted to Book Value : 0.19% (As of Sep. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG ROE % Adjusted to Book Value?

Sartorius AG's ROE % for the quarter that ended in Sep. 2024 was 1.24%. Sartorius AG's PB Ratio for the quarter that ended in Sep. 2024 was 6.52. Sartorius AG's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 0.19%.

Sartorius AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Sartorius AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG ROE % Adjusted to Book Value Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.26

1.00

0.86

3.29

0.92

Sartorius AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															0.18	2.28	0.66	0.64	0.19

Competitive Comparison of Sartorius AG's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Sartorius AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius AG's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sartorius AG's ROE % Adjusted to Book Value falls into.

Sartorius AG ROE % Adjusted to Book Value Calculation

Sartorius AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.12%	/	11.03
	=	0.92%

Sartorius AG's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.24%	/	6.52
	=	0.19%

Sartorius AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sartorius AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT:Italy 1SRT3:Italy SRT3d:UK 0NIR:UK 0NIQ:UK SRT3:Bulgaria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Executives

Dr. Lothar Ewald Kappich	Supervisory Board
Dr. Joachim Kreuzburg	Board of Directors

Sartorius AG Headlines

No Headlines